Ardent Health Income Statement (2022-2026) | ARDT

Income Statement Dec2022 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Revenue & cost
Revenue (Quarter) 1,368.73M1,377.73M1,346.03M1,439.05M1,470.92M1,449.82M1,606.29M1,497.23M1,645.28M1,576.75M1,605.08M1,601.87M
Cost of Revenue (Quarter) 108.83M124.64M-291.98M257.78M115.32M117.70M678.27M130.77M163.70M198.71M277.53M165.15M
Gross Profit (Quarter) 1,259.90M1,253.09M1,638.01M1,181.27M1,355.60M1,332.12M928.02M1,366.47M1,481.58M1,378.03M1,327.55M1,436.72M
Operating items
Other Operating Expenses (Quarter) 1,275.51M1,307.25M1,312.99M1,345.28M1,351.77M1,366.34M1,401.23M1,395.28M1,495.46M1,552.56M1,485.09M1,488.59M
Operating Expenses (Quarter) 1,300.92M1,331.76M1,337.21M1,382.48M1,388.74M1,392.75M1,439.04M1,423.04M1,523.29M1,578.95M1,512.71M1,527.28M
Operating Income (Quarter) -41.01M-78.67M300.80M-201.22M-33.14M-60.63M-511.02M-56.57M-41.71M-200.92M-185.16M-90.56M
EBIT (Quarter) -41.01M-78.67M300.80M-201.22M-33.14M-60.63M-511.02M-56.57M-41.71M-200.92M-185.16M-90.56M
Non-operating items
Other Non Operating Income (Quarter) -1.90M
Non Operating Income (Quarter) 0.52M1.09M0.26M2.81M23.20M21.28M-0.56M2.60M5.89M
Net income details
EBT (Quarter) 67.82M45.97M8.83M56.56M82.18M57.07M167.25M74.20M121.99M-2.20M92.37M74.59M
Tax Provisions (Quarter) 12.10M7.26M-1.96M10.70M15.20M11.06M26.36M15.20M26.30M-3.41M18.12M16.10M
Profit After Tax (Quarter) 33.08M20.84M-4.15M27.05M42.77M26.32M140.89M41.38M72.95M-23.48M74.26M39.85M
Income from Non-Controlling Interests (Quarter) 22.63M17.87M14.93M18.80M24.19M19.68M26.69M17.58M22.75M24.68M29.31M18.64M
Income from Continuing Operations (Quarter) 55.72M38.71M10.79M45.86M66.98M46.01M140.89M59.00M95.69M1.21M74.25M58.49M
Consolidated Net Income (Quarter) 55.72M38.71M10.79M45.86M66.98M46.01M140.89M59.00M95.69M1.21M74.25M58.49M
Income towards Parent Company (Quarter) 55.72M38.71M10.79M45.86M66.98M46.01M140.89M59.00M95.69M1.21M74.25M58.49M
Net Income towards Common Stockholders (Quarter) 55.72M38.71M10.79M45.86M66.98M46.01M140.89M59.00M95.69M1.21M74.25M58.49M
Additional items
EPS (Basic) (Quarter) 0.260.17-0.030.210.340.190.850.300.52-0.170.310.28
EPS (Weighted Average and Diluted) (Quarter) 0.260.17-0.030.210.340.190.840.290.52-0.170.320.28
Shares Outstanding (Weighted Average) (Quarter) 126.12M126.12M126.12M126.12M126.12M126.12M129.88M132.44M140.06M140.22M141.23M140.76M141.27M
Shares Outstanding (Diluted Average) (Quarter) 126.12M126.12M126.12M126.12M126.12M126.12M130.02M132.74M140.70M141.11M141.24M141.45M141.78M
EBITDA (Quarter) -41.01M-78.67M300.80M-201.22M-33.14M-60.63M-511.02M-56.57M-41.71M-200.92M-185.16M-90.56M
Interest Expenses (Quarter) 18.69M19.04M18.45M19.26M18.16M14.63M13.53M14.18M14.73M13.91M12.38M12.21M
Tax Rate (Quarter) 17.84%15.80%-22.24%18.92%18.50%19.38%15.76%20.49%21.56%154.79%19.62%21.59%